FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention is related to compounds of general formula (I) 
where: R1 and R2 either identical or the same represent: hydrogen atom or halogen atom, CN or NO2, with R1 and R2 being other than hydrogen atom simultaneously; m means: 1 or 2, n means: 0, 1 or 2; R3 represents: phenyl radical either substituted or unsubstituted by one or more radical selected halogen atom, hydroxyl group or C1-C6 alkyl group; C2-C6 alkyl group either substituted or unsubstituted by one or more radicals selected from halogen atom or hydroxyl group; cycloalkyl group; pyridine; thiophene; pyrrole either substituted or unsubstituted by C1-C6 alkyl group; thiazole or furan; or to therapeutically acceptable salts or solvates.
EFFECT: invention refers to methods for preparing the compounds of formula I, to based pharmaceutical compositions showing antithrombotic activity, as well as to the use of these compounds for preparing a antiaggregant.
11 cl, 36 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CINNAMOYL-PIPERAZINE DERIVATIVES AND THEIR APPLICATION AS PAR-1 ANTAGONISTS | 2007 |
|
RU2440997C2 |
| SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
| NEW ARYL - AND HETEROARYLPIPERAZINES | 2003 |
|
RU2361869C2 |
| METHOD FOR TREATMENT ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2277909C2 |
| ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2539591C2 |
| HETEROCYCLIC COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DISEASES ASSOCIATED WITH METABOTHROPHIC GLUTAMATE RECEPTORS | 2000 |
|
RU2296127C9 |
| QUINOXALINES AND AZAQUINOXALINES AS CRTH RECEPTOR MODULATORS | 2011 |
|
RU2589709C2 |
| DIARYL-SUBSTITUTED 6,5-CONJUGED CYCLIC COMPOUNDS AS C5aR INHIBITORS | 2018 |
|
RU2796983C2 |
| CHROMONE DERIVATIVES, METHOD FOR PREPARING THEM AND THERAPEUTIC USES THEREOF | 2010 |
|
RU2545214C2 |
| 1,2,4-TRIAZINE-3-AMINE DERIVATIVES | 2011 |
|
RU2771819C2 |
